Evidence for empagliflozin in heart failure with preserved ejection fraction (HFpEF). Issue 2 (12th December 2022)

Record Type:: Journal Article
Title:: Evidence for empagliflozin in heart failure with preserved ejection fraction (HFpEF). Issue 2 (12th December 2022)
Main Title:: Evidence for empagliflozin in heart failure with preserved ejection fraction (HFpEF)
Authors:: Adeyeye, Elizabeth
Khong, Teck K
Abstract:: Abstract: Commentary on: Anker SD, Butler J, Filippatos G, et al . Empagliflozin in heart failure with a preserved ejection fraction. New England Journal of Medicine, 2021; 385:1451–61.
Is Part Of:: Drug and therapeutics bulletin. Volume 61:Issue 2(2023)
Journal:: Drug and therapeutics bulletin
Issue:: Volume 61:Issue 2(2023)
Issue Display:: Volume 61, Issue 2 (2023)
Year:: 2023
Volume:: 61
Issue:: 2
Issue Sort Value:: 2023-0061-0002-0000
Page Start:: 22
Page End:: 23
Publication Date:: 2022-12-12
Subjects:: Heart failure -- Cardiovascular Diseases
Drugs -- Periodicals
Therapeutics -- Periodicals
Pharmacology -- Periodicals
615.5
Journal URLs:: http://dtb.bmj.com/ ↗
http://www.bmj.com/archive ↗
DOI:: 10.1136/dtb.2022.000060 ↗
Languages:: English
ISSNs:: 1755-5248
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 25490.xml